Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07894575
Recruiting Not applicable

Impact of Septoplasty on Headache

NCT07894575 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sohag University
Phase
Not applicable
Started
2026-08-20
Last updated
2026-10-26

Condition(s) studied

Impact of Septoplasty on Headache

Investigational drug(s) / intervention(s)

Septoplasty

Septoplasty: Surgical correction of the deviated nasal septum and evaluate its clinical impact on improving patients' headache

Study summary

Impact of septoplasty on headache if there is improvement or changes in headache severity before and after operation

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: 1. age \[18 - 60\] years 2. patients who have septal deviation and headache Exclusion Criteria: 1. Nasal diseases as Allergic rhinitis , Acute and chronic sinusitis , Nasal Polyps , granulomatous diseases , septal perforation 2. Past history of nasal surgery 3. systemic diseases as hypertension , diabetes , anemia , Blood diseases 4. ophthalomological causes : Glaucoma ; Refractive errors. 5. cervical spine and temporomandibular joint problems 6. congential anomalies as Cleft lips or palate 7. neurological causes: vascular headache; tension headache; cluster headache ; migraine ; stroke ; epilepsy; tumors. 8. dental causes: Untreated dental caries associated with pain ; teeth grinding ; recent dental procedures ; dental inflammation or abscess \-

Primary outcome measure(s)

  • Change in Headache Severity before and after septoplasty — Preoperatively and postoperatively at 1 month ; 3 month ; 6 month
    Headache severity will be assessed using the Visual Analogue Scale (VAS), where scores range from 0 (no pain) to 10 (worst possible pain). Higher scores indicate more severe headache.

Trial sites (1)

FacilityCityRegionStatus
Sohag university Sohag Egypt Recruiting

More Sohag University trials in Egypt

Colitis Patterns in Patients With Lower GI Symptoms Starting soon
Zadek Osteotomy for Treatment of Haglund's Syndrome Recruiting
Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patient. Active, not recruiting
Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders Starting soon
Accuracy of Transabdominal Ultrasound in Predicting Intraperitoneal Adhesions Prior to Laparoscopy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07894575 on ClinicalTrials.gov ↗ ← All trials in Egypt